A Phase 1 study of the blood-stage malaria vaccine candidate AMA1-C1/Alhydrogel® with CPG 7909, using two different formulations and dosing intervals
Ruth D. Ellis, Gregory E.D. Mullen, Mark Pierce, Laura B. Martin, Kazutoyo Miura, Michael P. Fay, Carole A. Long, Donna Shaffer, Allan Saul, Louis H. Miller, Anna P. Durbin
Dive into the research topics of 'A Phase 1 study of the blood-stage malaria vaccine candidate AMA1-C1/Alhydrogel® with CPG 7909, using two different formulations and dosing intervals'. Together they form a unique fingerprint.